预览加载中,请您耐心等待几秒...
1/10
2/10
3/10
4/10
5/10
6/10
7/10
8/10
9/10
10/10

在线预览结束,喜欢就下载吧,查找使用更方便

如果您无法下载资料,请参考说明:

1、部分资料下载需要金币,请确保您的账户上有足够的金币

2、已购买过的文档,再次下载不重复扣费

3、资料包下载后请先用软件解压,在使用对应软件打开

耐亚胺培南铜绿假单胞菌的临床分离及耐药机制分析[摘要]目的:了解我院耐亚胺培南铜绿假单胞菌(IRPA)的临床分布情况并探讨其耐药机制。方法:对2009年1月~2010年12月我院住院患者临床分离的非重复性IRPA的数据资料进行统计分析采用PCR方法检测金属酶基因和外膜通道蛋白基因。结果:从404株铜绿假单胞菌中共分离出100株IRPA分离率为24.75%。其中90株(90.0%)IRPA来源于下呼吸道痰液标本;IRPA主要来源于重症医学科(ICU);IRPA对阿米卡星最敏感率为73.0%(耐药率为27.0%)其次是哌拉西林/他唑巴坦(敏感率为63.0%)哌拉西林(敏感率为59.0%)庆大霉素(敏感率为58.0%)头孢他啶(敏感率为57.0%)其余药物的敏感率均[关键词]铜绿假单胞菌;亚胺培南;耐药性[中图分类号]R378[文献标识码]B[文章编号]1673-7210(2011)12(b)-092-03ClinicaldistributionandantimicrobialresistancemechanismofImipenem-resistantpseudomonasaeruginosaLIANJie1MAILiwen1YUZhijian2DENGQiwen2*1.DepartmentofCentrelLaboratoryNanshanHospitalAffiliatedtoGuangdongMedicalCollegeGuangdongProvinceShenzhen518052China;2.DepartmentofInfectiousDiseaseNanshanHospitalAffiliatedtoGuangdongMedicalCollegeGuangdongProvinceShenzhen518052China[Abstract]Objective:ToinvestigatetheclinicaldistributionandantimicrobialresistancemechanismofImipenem-resistantpseudomonasaeruginosa(IRPA).Methods:Dataonnon-recurrentIRPAisolatedfrominpatientsofthishospitalfromJanaury2009toDecember2010werestatisticallyanalyzed.β-lactamasegeneandtheoutermembranechannelproteingeneweredeterminatedbyusingPCRmethod.Results:404strainsofP.aeruginosa100strainswereresistanttoImipenemindicatingthatIRPAwasisolatedatarateof24.75%.Ofthesestrains90strains(90.0%)wereprimarilyisolatedfromsputum.IRPAoriginatedprimarilyinICU.ThelowestdrugresistancewastoAmikacin(27.0%)followedbyPiperacillin/Tazobactam(63.0%)Piperacillin(59.0%)Gentamicin(58.0%)Ceftazidime(57.0%)theratesofdrugresistancetotheotherantibioticswerelessthan50.0%.OnlyonestrainofIRPAwasdetectedpositivebyIMPgene(1.0%)andsequencingresultshoweditwasaIMP-9typemetallo-β-lactamases(MBL)genewhileotherMBLgeneswerenotdetected.TheabsentrateofoprD2genewas65.0%.Conclusion:ThelossofoprD2